Virginia Bioinformatics Institute (VBI), a world-class research institute dedicated to the study of information biology, is using DataDirect Networks (DDN) SFA® high-performance storage engine-based GRIDScaler GPFS parallel file system to perform rapid, accurate Ebola outbreak modeling for the U.S. Department of Defense’s Defense Threat Reduction Agency (DTRA).
A team of 30 researchers and scientists on VBI’s Ebola rapid response team initially provided DTRA and West Africa’s Ministries of Health (MOH) with short-term forecasts on vaccine production and disease spread.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7429756-ddn-gridscaler-vbi-ebola/
Hospital-acquired infections can be deadly – and many times preventable. Nearly every major public health organization agrees that ineffective “hand-hygiene” (hand washing or using disinfecting sprays, wipes or gels) is one of the most significant contributors to the problem. Further compounding the problem is the fact that compliance rates among caregivers are difficult to track and often found to be low.
Hill-Rom has developed a new system to help hospitals monitor hand-hygiene rates: the Hill-Rom® Hand Hygiene Compliance Solution. The new offering, which is now available to hospitals nationwide, provides real-time monitoring and staff reminders, simplifies reporting, and can use the same hardware and devices as other Hill-Rom real-time locating solutions.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61990-hill-rom-launches-new-hospital-hand-hygiene-monitoring-solution
Persistent deterioration of short-term memory, progressive confusion and disorientation and frequent agitation are characteristic of Alzheimer’s disease. We have been told that it is largely genetic but that there are some things that can be done to reduce the severity or how early the onset is. We can’t change our genetic makeup but we can change our behavior to help mitigate the effects of this type of dementia. These are all things we can accomplish with a little determination and planning. http://youtu.be/9eMrmVMuAa0
For the first time ever in the UK, a gluten-free breakfast cereal will sit alongside other well-known brands in the mainstream cereal aisle, marking a breakthrough in the availability of gluten-free cereal products.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/72762533-nestle-gluten-free-cereal-launch/
Seqirus is now shipping its complete portfolio of seasonal influenza vaccines to customers in the US market for the 2016-2017 season. Seqirus is the only influenza vaccine manufacturer to produce influenza vaccines using both egg-based and cell culture technologies, and the only provider in the US that offers both quadrivalent and trivalent influenza vaccines, as well as the only adjuvanted seasonal influenza vaccine.
Seqirus is now shipping to the US all influenza vaccines in its portfolio, including Fluad™ (Influenza Vaccine, Adjuvanted), Flucelvax Quadrivalent™ (Influenza Vaccine), Afluria® (Influenza Vaccine), and Fluvirin® (Influenza Virus Vaccine) in advance of the peak of influenza season.
“Seqirus is proud to be a major contributor to the prevention and control of influenza by offering healthcare providers and pharmacists with a range of clinically proven, innovative vaccination options that help protect people against the debilitating effects of the disease,” said Brent MacGregor, Senior Vice President, Commercial Operations. “We are committed to being an early and reliable supplier of our influenza vaccines to help ensure that appropriate patients have plenty of time to get their annual immunization.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7902351-seqirus-franchise-shipment/
Having lost his mother to the disease, singer, songwriter Gavin DeGraw knows firsthand how devastating pancreatic cancer is for patients and their families. Gavin is turning his grief into action by helping the Lustgarten Foundation raise awareness by encouraging people to get involved with the Foundation.
“My mother didn’t make it and unfortunately right now that’s a common story. But it doesn’t have to be the story permanently,” DeGraw said. “By funding research, the Lustgarten Foundation is going to change the course of this disease. I encourage everyone to get involved in some way – join a walk or make a donation.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8213753-lustgarten-foundation-pancreatic-cancer-awareness/
Abbott announced today that the U.S. Food and Drug Administration has approved the company’s Absorb bioresorbable heart stent, making the first-of-its-kind medical device commercially available to treat people with coronary artery disease in the United States.
Absorb is the only fully dissolving stent approved for the treatment of coronary artery disease, which affects 15 million people in the United States and remains a leading cause of death worldwide, despite decades of therapeutic advances. While stents are traditionally made of metal, Abbott’s Absorb stent is made of a naturally dissolving material, similar to dissolving sutures. Absorb disappears completely in approximately three years, after it has done its job of keeping a clogged artery open and promoting healing of the treated artery segment. By contrast, metal stents are permanent implants that restrict vessel motion for the life of the person treated.
To view the multimedia release go to:
http://www.multivu.com/players/English/7826651-abbott-fda-approval-stent/
This year's Red Dress Collection℠ kicked off Mercedes-Benz Fashion Week in New York City last night with notables such as Lindsey Vonn, AnnaSophia Robb, Colbie Caillat, Giada De Laurentiis, Bella Thorne and Daphne Oz showing off some of the hottest designers’ red gowns to bring awareness to the number 1 killer of women – heart disease.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/64681-aha-and-macy-s-go-red-for-women/
The Leukemia & Lymphoma Society (LLS) today announced it has committed $28.6 million in new research investment to advance the most promising blood cancer science at leading academic and medical institutions around the world, including Dana-Farber Cancer Institute, Weill Cornell Medical College and MD Anderson Cancer Center. As LLS leads the charge to find cures for cancer patients, this new funding, along with ongoing investment in LLS’s aggressive research agenda, brings LLS’s total commitment to blood cancer research to more than $1 billion. The investment has led to the development of nearly every therapy currently used to treat the blood cancers.
Along with these new research grants, LLS remains committed to collaborating with biotechnology companies through its innovative Therapy Acceleration Program® (TAP), a model pioneered by LLS in the cancer arena in recognition that traditional research approaches weren’t yielding treatments and cures fast enough for patients. LLS commits approximately $13 million a year to its TAP initiatives. As part of the 24 current such collaborations, LLS recently initiated new investments with Kite Pharma and OncoPep.
To view the multimedia release go to:
http://www.multivu.com/players/English/7554852-lls-cancer-research-funding/
The National Meningitis Association (NMA) today announced the launch of a new educational initiative in collaboration with Sanofi Pasteur, the vaccines division of Sanofi, about the importance of the Centers for Disease Control and Prevention’s (CDC’s) recommended second dose of the meningococcal meningitis vaccine (MenACWY) for adolescents at age 16. The 16 Vaccine (The16Vaccine.org) aims to educate parents about the importance of this critical second dose of MenACWY, which helps protect teens against meningococcal meningitis during the period when they are at increased risk.
To view the multimedia release go to:
https://www.multivu.com/players/English/8385951-national-meningitis-association-the-16-vaccine/
Jewelry Television® will support the American Heart Association’s Go Red For Women® this month to help fight heart disease. The shopping network will roll out ‘Love Your Heart,’ a comprehensive, multimedia campaign created to raise awareness and educate viewers about the risks of heart disease, and raise funds to support the Go Red for Women® movement.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/65489-jewelry-television-supports-american-heart-association-go-red-for-women
The National Climate Assessment: Climate Change Impacts in the United States concludes that warmer and drier conditions have already contributed to increasing wildfire events across the western United States, and future increases are projected in some regions. Already this year, there have been over 44,000 wildfires that have damaged or destroyed almost 8.5 million acres. Long periods of record high temperatures are associated with droughts that contribute to dry conditions and drive wildfires in some areas.
USDA Secretary Vilsack recently stated, “This year, we are experiencing yet another devastating wildfire season, particularly in the drought-ravaged West. Climate change, drought, fuel buildup, insects and disease are increasing the severity of unprecedented wildfire in America's forests and rangelands, which impacts the safety of people, homes and communities. Development close to forests has also increased the threat to property, with more than 46 million homes in the United States, or about 40 percent of our nation's housing, potentially at risk from wildfire.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7607931-fema-national-prepareathon/
